Studies on aducanumab were halted earlier this year because the drug didn't appear to be effective. But the new results suggest it's effective at a high dose, the Associated Press reported....
Become a member to take advantage of more features, like commenting and voting.
Register or sign in today!
Become a member to take advantage of more features, like commenting and voting.
Register or sign in today!